Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
Dr. Allison Betof Warner from Stanford University joins Rahul Gosain, MD and Rohit Gosain, MD, on the Oncology Brothers podcast to discuss melanoma treatment. The conversation covers the…
NEW YORK (Reuters Health) – A large increase in the number of lymph nodes evaluated during surgery for colon cancer — a quality improvement metric– has not had…
NEW YORK (Reuters Health) – Patients undergoing surgery for spinal metastases at teaching hospitals in July have higher mortality and complication rates than similar patients treated in other…
NEW YORK (Reuters Health) – Endoscopic ablation of Barrett’s esophagus can bury metaplastic glands under a layer of neosquamousepithelium. However, how often this happens and its importance still…
NEW YORK (Reuters Health) – Patients with prostate cancer involving the seminal vesicle and who undergo radical prostatectomy fare best when given adjuvant radiotherapy plus androgen deprivation therapy,…
NEW YORK (Reuters Health) – New data from phase III randomized clinical trials have prompted a focused update of one recommendation contained in the 2009 American Society of…
NEW YORK (Reuters Health) – A Canadian guideline on ovarian ablation in premenopausal women with breast cancer has been endorsed by the American Society of Clinical Oncology (ASCO),…
NEW YORK (Reuters Health) – An analysis of epidemiologic data confirms that the incidence of second primary malignancies is increased after external beam radiotherapy (EBRT) for stage I…
NEW YORK (Reuters Health) – Dexamethasone may be a useful supplement to standard treatment of certain patients with acute monocytic leukemia, French researchers report in an August 4th…
NEW YORK (Reuters Health) – Surgery offers the best hope for survival in patients with the rare intracranial hemangiopericytoma (HPC), researchers from San Francisco report in the August…
NEW YORK (Reuters Health) – The combination of epirubicin and ifosfamide is effective in patients with relapsed or refractory small cell lung cancer (SCLC), researchers from France report…
